Continuous glucose monitoring technology for personal use: an educational program that educates and supports the patient.
The purpose of this article is to describe the development and implementation of an educational program for the initiation of real-time continuous glucose monitoring (CGM) technology for personal use, not 3-day CGMS diagnostic studies. The education program was designed to meet the needs of patients managing their diabetes with either diabetes medications or insulin pump therapy in an outpatient diabetes education center using a team-based approach.



Observational research, complemented by literature review, was used to develop an educational program model and teaching strategies. Diabetes educators, endocrinologists, CGM manufacturer clinical specialists, and patients with diabetes were also interviewed for their clinical observations and experience.



The program follows a progressive educational model. First, patients learn in-depth about real-time CGM technology by attending a group presensor class that provides detailed information about CGM. This presensor class facilitates self-selection among patients concerning their readiness to use real-time CGM. If the patient decides to proceed with real-time CGM use, CGM initiation is scheduled, using a clinic-centered protocol for both start-up and follow-up.



Successful use of real-time CGM involves more than just patient enthusiasm or interest in a new technology. Channeling patient interest into a structured educational setting that includes the benefits and limitations of real-time CGM helps to manage patient expectations.
Evert
Alison
A
The Diabetes Care Center, University of Washington Medical Center, Seattle
Trence
Dace
D
The Diabetes Care Center, University of Washington Medical Center, Seattle
Catton
Sarah
S
The Diabetes Care Center, University of Washington Medical Center, Seattle
Huynh
Peter
P
The Diabetes Care Center, University of Washington Medical Center, Seattle
D000328:Adult; D001786:Blood Glucose / Q000032:analysis*; D003920:Diabetes Mellitus / Q000097:blood* / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007332:Insulin Infusion Systems; D018670:Monitoring, Ambulatory / Q000379:methods*; D010353:Patient Education as Topic; D017060:Patient Satisfaction; D012648:Self Care; D013663:Teaching / Q000379:methods
D001786:Blood Glucose; D007004:Hypoglycemic Agents